Dipan Patel - 31 Dec 2025 SCHEDULE 13D/A Report for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX)

Filing Manager: Dipan Patel
Reporting Manager: Patel Dipan
Security: Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01
Symbol: AMRX
Shares outstanding: 313,041,907 shares
Disclosed Ownership: 16,904,263 shares
Ownership: 5.4%
Form type: SCHEDULE 13D/A
Filing time: 26 Mar 2026, 18:23:15 UTC
Date of event: 31 Dec 2025
Previous filing: 06 Oct 2025
SEC: View on sec.gov

Quoteable Key Fact

"Dipan Patel disclosed 5.4% ownership in Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX) on 31 Dec 2025."

Quick Takeaways

Dipan Patel filed SCHEDULE 13D/A for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX).
Disclosed ownership: 5.4%.
Date of event: 31 Dec 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Patel Dipan	5.4%	16,904,263	16,904,263	0	Dipan Patel	Patel Dipan	0001745437